通过血小板PECAM1抑制糖蛋白VI和整合素α2β1依赖的血栓形成
Natalie J Jooss1,2,3, Marije G Diender4, Delia I Fernández1,5
1Department of Biochemistry, Maastricht University, Maastricht, The Netherlands.
Cellular and molecular life sciences : CMLS
|January 18, 2024
概括
血小板受体整合素α2β1可以覆盖PECAM1和PTPN11对血栓形成的抑制作用,特别是在诺南综合征患者中. 这种相互作用会影响原介导的血小板聚合.
科学领域:
- 血液学 血液学 血液学
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 血小板受体葡萄糖蛋白VI (GPVI) 和整体蛋白α2β1是原诱导血栓形成的关键调节者.
- ITIM受体PECAM1及其下游酸酶PTPN11在调节这一过程中的作用仍然不清楚.
研究的目的:
- 研究整合素α2β1在PECAM1-和PTPN11依赖性血栓形成中的协调作用.
- 阐明PECAM1,PTPN11和整合素α2β1在流动条件下的血小板聚合中的相互作用.
主要方法:
- 研究了不同类型的原蛋白 (I,III,IV) 的流动下的血小板激活,具有不同的GPVI依赖性.
- 在健康受试者和诺南综合征患者中利用整合素α2β1阻断和PECAM1抑制.
- 分析了血栓参数,以评估受体调节的影响.
主要成果:
- 仅仅抑制PECAM1并没有改变不同原体的对照血液中的血栓形成.
- 整体素α2β1阻塞通常会降低血栓参数,最显著的是原IV.
- 同时抑制PECAM1和α2β1恢复了血栓形成,这表明α2β1掩盖了PECAM1的抑制信号.
- 具有PTPN11功能获取突变的诺南患者表现出可变的血栓形成,α2β1阻塞效应被PECAM1抑制抵消.
结论:
- 整体素α2β1的参与可以克服PECAM1和PTPN11对GPVI依赖性血栓形成的抑制作用.
- 这些发现揭示了一个复杂的调节网络,涉及这些血小板受体在血液静止中.
- 了解这种相互作用可能有助于了解诸如努南综合征之类的出血障碍.
相关概念视频
Intracellular Signaling Affects Focal Adhesions
2.7K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.7K
Formation of the Platelet Plug
6.3K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.3K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
701
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
701
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
525
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
525
Clot Retraction and Fibrinolysis
6.0K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.0K
Structure and Function of Platelets
1.2K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
1.2K


